Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years – The RECOVER study

Autor: Mainz, Jochen G., Lester, Karen, Elnazir, Basil, Williamson, Michael, McKone, Ed, Cox, Des, Linnane, Barry, Zagoya, Carlos, Duckstein, Franziska, Barucha, Anton, Davies, Jane C., McNally, Paul
Zdroj: In Journal of Cystic Fibrosis May 2024 23(3):474-480
Databáze: ScienceDirect
Externí odkaz: